We are live on ! Find out more
BIO.B icon

Bio-Rad Laboratories Class B
BIO.B

6 hedge funds and large institutions have $7.92M invested in Bio-Rad Laboratories Class B in 2018 Q1 according to their latest regulatory filings, with funds opening new positions, 1 increasing their positions, 0 reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

5% more capital invested

Capital invested by funds: $7.55M → $7.92M (+$375K)

0.01% more ownership

Funds ownership: 0.61% → 0.62% (+0.01%)

0% more funds holding

Funds holding: 6 → 6 (0)

Holders
6
Holders Change
–
Holders Change %
0%
% of All Funds
0.14%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
1
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$113K

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
CL
1
CSS LLC
Illinois
$5.6M – – –
Dimensional Fund Advisors
2
Dimensional Fund Advisors
Texas
$1.61M – – –
Susquehanna International Group
3
Susquehanna International Group
Pennsylvania
$366K +$113K +436 +42%
Renaissance Technologies
4
Renaissance Technologies
New York
$276K – – –
UBS Group
5
UBS Group
Switzerland
$67K – – –
Bank of America
6
Bank of America
North Carolina
$1K – – –

BIO.B Hedge Fund Activity: Q1 2018 in Review

6 of the 4,363 institutional investors tracked by Wall St. Rank reported a position in Bio-Rad Laboratories Class B (BIO.B) for Q1 2018, worth a combined $7.92M — up 5% from $7.55M a quarter earlier.

Fund positioning in BIO.B was balanced in Q1 2018: 0 funds opened new positions, 0 closed out, 1 added to existing stakes and 0 trimmed.

The largest buyer was Susquehanna International Group, adding an estimated $113K.

  • 6 institutional investors held Bio-Rad Laboratories Class B (BIO.B) as of Q1 2018, unchanged from Q4 2017.
  • Funds reported $7.92M of Bio-Rad Laboratories Class B stock for Q1 2018, up 5% quarter-over-quarter.
  • 0 funds opened new Bio-Rad Laboratories Class B positions in Q1 2018 and 0 closed out.
  • The largest Bio-Rad Laboratories Class B buyer in Q1 2018 was Susquehanna International Group, an estimated $113K added.

Based on aggregated 13F filings for Q1 2018.